Table 2. Treatment after the index thrombosis.
Total (%) |
Cytoreductiona |
||
---|---|---|---|
Yes | No | ||
VKA | 143 (79.0) | 101 (70.6) | 42 (29.4) |
VKA+antiplatelets | 10 (5.5) | 6 (60.0) | 4 (40.0) |
Antiplatelets | 6 (3.3) | 6 (100) | 2 (0) |
Heparin | 10 (5.5) | 7 (70.0) | 3 (30.0) |
DOACs | 3 (1.7) | 2 (66.7) | 1 (33.3) |
No antithrombotic treatment | 9 (5.0) | 8 (88.9) | 1 (11.1) |
Total (%) | 181 (100) | 130 (71.8) | 51 (28.2) |
Abbreviations: DOAC, direct oral anticoagulant; VKA, vitamin K-antagonists.
Hydroxyurea in 108/130 cases (83%).